Last quarter (Q ), BioForce Nanosciences Holdings's total revenue was $―, a decrease of ― from the same quarter last year. In Q, BioForce Nanosciences Holdings's net income was $-113.60K. See BioForce Nanosciences Holdings’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	-	-	-	$ 0.00	$ 17.77K	$ 16.31K
Cost of Revenue	-	-	-	$ 0.00	$ 13.41K	$ 11.64K
Gross Profit	-	-	-	$ 0.00	$ 4.36K	$ 4.67K
Operating Expense	$ 242.81K	$ 485.51K	$ 501.95K	$ 158.41M	$ 50.90K	$ 71.41K
Operating Income	$ -472.28K	$ -485.51K	$ -501.95K	$ -158.41M	$ -46.54K	$ -66.74K
Net Non Operating Interest Income Expense	-	-	-	-	-	-
Other Income Expense	-	-	-	-	-	$ -998.00
Pretax Income	$ -472.28K	$ -485.51K	$ -501.95K	$ -158.41M	$ -46.54K	$ -67.74K
Tax Provision	-	-	-	-	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -472.27K	$ -485.51K	$ -501.95K	$ -158.41M	$ -46.54K	$ -67.74K
Basic EPS	$ -29.27M	-	$ -0.02	$ -9.72	$ >-0.01	$ >-0.01
Diluted EPS	-	-	$ -0.02	$ -9.72	$ >-0.01	$ >-0.01
Basic Average Shares	$ 58.54M	-	$ 29.27M	$ 16.30M	$ 15.26M	$ 15.26M
Diluted Average Shares	$ 58.54M	-	$ 29.27M	$ 16.30M	$ 15.26M	$ 15.26M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 242.81K	$ 485.51K	$ 501.95K	$ 158.41M	$ 64.31K	$ 83.05K
Net Income From Continuing And Discontinued Operation	$ -472.28K	$ -485.51K	$ -501.95K	$ -158.41M	$ -46.54K	$ -67.74K
Normalized Income	$ -90.00K	-	-	$ -158.41M	$ -46.54K	$ -66.74K
Interest Expense	-	-	-	-	-	-
EBIT	$ -472.28K	$ -485.51K	$ -501.95K	$ -158.41M	$ -46.54K	$ -66.74K
EBITDA	$ -358.67K	$ -485.51K	$ -501.95K	$ -158.41M	$ -46.54K	$ -66.74K

Currency in USD

BioForce Nanosciences Holdings Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing